企業(yè)認(rèn)證
Curia Global, Inc.
CURIA，前身為Albany Molecular Research, Inc. (AMRI)，成立于1991年，是一家全球性的合同研究、開發(fā)和制造組織（CDMO）。CURIA提供覆蓋藥物開發(fā)全譜的產(chǎn)品和服務(wù)，幫助合作伙伴將其想法轉(zhuǎn)化為現(xiàn)實(shí)，從而提高商業(yè)績效并改善患者生活。CURIA通過其在北美、歐洲和亞洲的分支機(jī)構(gòu)，為全球的制藥和生物技術(shù)公司提供支持。CURIA擁有深厚的科研和技術(shù)專長，提供包括生物學(xué)研究、化學(xué)過程研發(fā)、臨床生產(chǎn)、配方開發(fā)等多方面服務(wù)。通過不斷的技術(shù)創(chuàng)新和市場擴(kuò)展，CURIA已成為生命科學(xué)領(lǐng)域的重要參與者。
CURIA, formerly known as Albany Molecular Research, Inc. (AMRI), founded in 1991, is a global contract research, development, and manufacturing organization (CDMO). CURIA offers a broad range of products and services across the entire drug development spectrum to assist partners in transforming their ideas into reality, thereby enhancing business performance and improving patients' lives. With branches in North America, Europe, and Asia, CURIA supports pharmaceutical and biotechnology companies worldwide. Boasting profound research and technical expertise, CURIA provides various services including biology research, chemical process R&D, clinical production, and formulation development. Through continuous technological innovation and market expansion, CURIA has become an important player in the life sciences field.
| 公司成立時(shí)間 |
2020/11/13 0:00:00 |
注冊資本 |
美元20萬元 |
| 經(jīng)營范圍 |
醫(yī)藥信息咨詢(須經(jīng)審批的診療活動除外);健康管理、健康咨詢(須經(jīng)審批的診療活動除外);經(jīng)濟(jì)貿(mào)易咨詢:企業(yè)管理咨詢;企業(yè)策劃、設(shè)計(jì)、醫(yī)學(xué)研究與試驗(yàn)發(fā)展;技術(shù)開發(fā)、技術(shù)咨詢、技術(shù)轉(zhuǎn)讓、技術(shù)推廣、技術(shù)服務(wù)。(市場主體依法自主選擇經(jīng)營項(xiàng)目，開展經(jīng)營活動，依法須經(jīng)批準(zhǔn)的項(xiàng)目，經(jīng)相關(guān)部門批準(zhǔn)后依批準(zhǔn)的內(nèi)容開展經(jīng)營活動;不得從事國家和本市產(chǎn)業(yè)政策禁止和限制類項(xiàng)目的經(jīng)營活動。)
查看產(chǎn)品目錄 |
| 公司地址 |
26 Corporate Circle Albany, NY 12203 USA |
| 經(jīng)營模式 |
工廠 |
主營行業(yè) |
醫(yī)藥原料 |
該企業(yè)工商信息校驗(yàn)數(shù)據(jù)由天眼查提供